<p>John Beigel, an author, and Eddie Sullivan discuss a phase 1 study assessing the safety and tolerability of human antibodies manufactured in transchromosomic cows for treatment of MERS.</p>

John Beigel, an author, and Eddie Sullivan discuss a phase 1 study assessing the safety and tolerability of human antibodies manufactured in transchromosomic cows for treatment of MERS.

MERS and transchromosomic cows: The Lancet Infectious Diseases: January 10, 2018

The Lancet Infectious Diseases is a monthly journal, renowned for the publication of high-quality peer-reviewed reviews and analysis from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue.

Share MERS and transchromosomic cows: The Lancet Infectious Diseases: January 10, 2018

Sign up to save your podcasts

MERS and transchromosomic cows: The Lancet Infectious Diseases: January 10, 2018

MERS and transchromosomic cows: The Lancet Infectious Diseases: January 10, 2018